SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-302091
Filing Date
2023-12-22
Accepted
2023-12-22 16:00:30
Documents
14
Period of Report
2023-12-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d634539d8k.htm   iXBRL 8-K 34164
2 EX-10.1 d634539dex101.htm EX-10.1 67833
3 EX-10.2 d634539dex102.htm EX-10.2 24728
  Complete submission text file 0001193125-23-302091.txt   283129

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pkbo-20231218.xsd EX-101.SCH 2500
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pkbo-20231218_lab.xml EX-101.LAB 18700
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pkbo-20231218_pre.xml EX-101.PRE 11677
8 EXTRACTED XBRL INSTANCE DOCUMENT d634539d8k_htm.xml XML 3722
Mailing Address 4900 HOPYARD ROAD, SUITE 100 PLEASANTON CA 94588
Business Address 4900 HOPYARD ROAD, SUITE 100 PLEASANTON CA 94588 (925) 463-4800
Peak Bio, Inc. (Filer) CIK: 0001834645 (see all company filings)

IRS No.: 852448157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39951 | Film No.: 231509686
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)